Trial intelligence / Profile preview

INC280 plus PDR001 vs PDR001 monotherapy in advanced hepatocellular carcinoma

CTR20170838Phase 2Completed

Sponsor

Novartis

Start

Mar 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1